Buckley N A, Whyte I M, O'Connell D L, Dawson A H
Department of Clinical Pharmacology, Royal Adelaide Hospital, Australia.
J Toxicol Clin Toxicol. 1999;37(6):753-7. doi: 10.1081/clt-100102452.
The evidence for efficacy of gastric lavage and activated charcoal for gastrointestinal decontamination in poisoning has relied entirely on volunteer studies and/or pharmacokinetic studies and evidence for any clinical benefits or resource savings is lacking.
To investigate the value of gastrointestinal decontamination using gastric lavage and/or activated charcoal in acetaminophen (paracetamol) poisoning.
We analyzed a series of 981 consecutive acetaminophen poisonings. These patients were treated with gastric lavage and activated charcoal, activated charcoal alone, or no gastrointestinal decontamination. The decision as to which treatment was received was determined by patient cooperation, the treating physician, coingested drugs, and time to presentation after the overdose.
Of 981 patients admitted over 10 years, 10% (100) had serum concentrations of acetaminophen that indicated a probable or high risk of hepatotoxicity. The risk of toxic concentrations for patients ingesting less than 10 g of acetaminophen was very low. In patients presenting within 24 hours, who had ingested 10 g or more, those who had been given activated charcoal were significantly less likely to have probable or high risk concentrations (Odds ratio 0.36, 95% CI 0.23-0.58, p < 0.0001). Gastric lavage, in addition to activated charcoal, did not further decrease the risk (Odds ratio 1.12, 95% CI 0.57-2.20, p = 0.86).
Toxic concentrations of serum acetaminophen (paracetamol) are uncommon in patients ingesting less than 10 g. In those ingesting more, activated charcoal appears to reduce the number of patients who achieve toxic acetaminophen concentrations and thus may reduce the need for treatment and hospital stay.
洗胃和活性炭用于中毒时胃肠道去污的疗效证据完全依赖于志愿者研究和/或药代动力学研究,缺乏任何临床益处或资源节约方面的证据。
探讨洗胃和/或活性炭用于对乙酰氨基酚(扑热息痛)中毒时胃肠道去污的价值。
我们分析了连续的981例对乙酰氨基酚中毒病例。这些患者接受了洗胃和活性炭治疗、单独使用活性炭治疗或未进行胃肠道去污治疗。接受何种治疗的决定取决于患者的配合程度、治疗医生、同时摄入的药物以及过量服药后就诊的时间。
在10年期间收治的981例患者中,10%(100例)的对乙酰氨基酚血清浓度表明可能存在或有高度肝毒性风险。摄入对乙酰氨基酚少于10克的患者出现中毒浓度的风险非常低。在摄入10克或更多对乙酰氨基酚且在24小时内就诊的患者中,接受活性炭治疗的患者出现可能或高风险浓度的可能性显著降低(比值比0.36,95%可信区间0.23 - 0.58,p < 0.0001)。除活性炭外进行洗胃并未进一步降低风险(比值比1.12,95%可信区间0.57 - 2.20,p = 0.8)。
摄入少于10克对乙酰氨基酚的患者血清对乙酰氨基酚(扑热息痛)中毒浓度并不常见。对于摄入更多对乙酰氨基酚的患者,活性炭似乎可减少达到对乙酰氨基酚中毒浓度的患者数量,从而可能减少治疗需求和住院时间。